CN Patent

CN105168114A — 适合口服给药的鸟苷酸环化酶-c受体激动剂多肽的稳定的固体制剂

Assigned to Ironwood Pharmaceuticals Inc · Expires 2015-12-23 · 10y expired

What this patent protects

本文描述了适合口服给药的稳定的利那洛肽固体制剂，也描述了制备这样的制剂的方法。本文所述的制剂包含由氨基酸序列CysCysGluTyrCysCysAsnProAlaCysThrGlyCysTyr组成的多肽(“利那洛肽”)或其药学上可接受的盐。本文所述的利那洛肽制剂是稳定的，且具有对于生产、储存和分配该药物而言足够的贮存期限。

USPTO Abstract

本文描述了适合口服给药的稳定的利那洛肽固体制剂，也描述了制备这样的制剂的方法。本文所述的制剂包含由氨基酸序列CysCysGluTyrCysCysAsnProAlaCysThrGlyCysTyr组成的多肽(“利那洛肽”)或其药学上可接受的盐。本文所述的利那洛肽制剂是稳定的，且具有对于生产、储存和分配该药物而言足够的贮存期限。

Drugs covered by this patent

Patent Metadata

Patent number
CN105168114A
Jurisdiction
CN
Classification
—
Expires
2015-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Ironwood Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.